癌症的分子成像是一项协作努力，将不同领域的科学家和医生联合起来。这种合作正在积极开发和转化尖端分子成像方法，以增强人类恶性肿瘤的诊断前景。正电子发射断层扫描（PET）和PET成像示踪剂的出现，实现了分子水平上的无创靶标注释和肿瘤表征。在外科手术中，荧光或切伦科夫发光等新型成像技术有助于识别肿瘤并提高手术精度。同时，成像设备、创新算法和人工智能的进步为下一代癌症筛查和成像开辟了途径，提高了癌症诊断的效率和准确性。在这篇综述中，我们提供了分子癌症成像和该领域持续发展的全景。版权所有 © 2024 Elsevier Inc. 保留所有权利。

Molecular imaging of cancer is a collaborative endeavor, uniting scientists and physicians from diverse fields. Such collaboration is actively developing and translating cutting-edge molecular imaging approaches to enhance the diagnostic landscape of human malignancies. The advent of positron emission tomography (PET) and PET imaging tracers has realized non-invasive target annotation and tumor characterization at the molecular level. In surgical procedures, novel imaging techniques, such as fluorescence or Cherenkov luminescence, help identify tumors and enhance surgical precision. Simultaneously, progress in imaging equipment, innovative algorithms, and artificial intelligence has opened avenues for next-generation cancer screening and imaging, augmenting the efficiency and accuracy of cancer diagnosis. In this review, we provide a panorama of molecular cancer imaging and ongoing developments in the field.Copyright © 2024 Elsevier Inc. All rights reserved.